CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
ContributorsWang, Haiping; Franco, Fabien; Tsui, Yao-Chen; Xie, Xin; Trefny, Marcel P; Zappasodi, Roberta; Mohmood, Syed Raza; Fernández-García, Juan; Tsai, Chin-Hsien; Schulze, Isabell; Picard, Florence; Meylan, Etienne; Silverstein, Roy; Goldberg, Ira; Fendt, Sarah-Maria; Wolchok, Jedd D; Merghoub, Taha; Jandus, Camilla![orcid](assets/images/orcid.png)
; Zippelius, Alfred; Ho, Ping-Chih
![orcid](assets/images/orcid.png)
Published inNature Immunology, vol. 21, no. 3, p. 298-308
Publication date2020
Abstract
Affiliation Not a UNIGE publication
Research group
Funding
- Swiss National Science Foundation - Characterization of human lymphocytes expressing Siglec-9 in health and disease [PMPDP3_129022]
- Swiss National Science Foundation - Human innate lymphoid cells (ILCs): from their understanding at single cell level to defining their role in human cancer [PZ00P3_161459]
Citation (ISO format)
WANG, Haiping et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. In: Nature Immunology, 2020, vol. 21, n° 3, p. 298–308. doi: 10.1038/s41590-019-0589-5
Main files (1)
Article (Published version)
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiers
- PID : unige:132574
- DOI : 10.1038/s41590-019-0589-5
- PMID : 32066953
ISSN of the journal1529-2908